Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07398456 · ClinicalTrials.gov registry record · NA
Smartphone-enabled Hybrid Identification of Early CoLorectal Disease Using Blood-Based Cancer Testing Across TeXas
A NA study, sponsored by Baylor Research Institute.
- Not yet
- Registry status
- NA
- Development phase
- 5,500
- Enrollment target
NCT07398456: Clinical Trial NA study, sponsored by Baylor Research Institute.
NCT07398456 is a NA study that has not yet begun recruiting, run by Baylor Research Institute. The registered enrollment target is 5,500 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (292% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07398456, a NA study, has not yet begun recruiting, sponsored by Baylor Research Institute.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 5,500 participants
- Enrollment target
Study Summary
The goal of this prospective implementation study is to understand the impact of a blood-based screening test (BBST) for colorectal cancer (CRC) on patient acceptability of and adherence to CRC screening as well as the rate of follow-up BBST in those with negative BBST at a 1-year interval. Additional aims include assessing the impact of digital patient navigation intervention on the rate of follow-up colonoscopy in individuals with positive BBST. Patients will be randomized into the non-intervention arm or the intervention with an app arm.
Primary Outcome
Assess the number of patients with a negative BBST result who accept and complete a follow-up BBST.
Interventions
- OTHER Educational Information via Smartphone App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,500 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-06 |
| Phase | NA |
What is known before NCT07398456 opens enrollment
NCT07398456 is an interventional study that assigns participants to a tested intervention. Its 5,500 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (292% higher).
The record links to 0 conditions, and to 1 intervention - of which Educational Information via Smartphone App is the first listed.
NCT07398456 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07398456 about?
NCT07398456 is a clinical study titled "Smartphone-enabled Hybrid Identification of Early CoLorectal Disease Using Blood-Based Cancer Testing Across TeXas". The goal of this prospective implementation study is to understand the impact of a blood-based screening test (BBST) for colorectal cancer (CRC) on patient acceptability of and adherence to CRC screening as well as the rate of follow-up BBST in those with negative BBST at a 1-year interval. Additio...
What is the current status of trial NCT07398456?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 5,500 participants. The study started on 2026-06. Estimated completion is 2028-06.
What interventions are being tested in trial NCT07398456?
The interventions under investigation include: Educational Information via Smartphone App (OTHER).
Who is sponsoring clinical trial NCT07398456?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07398456's enrollment target sits among peer trials
5,500 24th of 2000 higher than 1,977 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05952557 · 5,500 participants · Phase 3
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
- NCT06084234 · 5,500 participants · Phase 4
National Liver Cancer Screening Trial
- NCT07146568 · 5,515 participants · NA
Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital
- NCT04295486 · 5,478 participants · Phase 2
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia